103 related articles for article (PubMed ID: 28157828)
1. Untying the Knot: What Lies Behind the Image?
Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):1. PubMed ID: 28157828
[No Abstract] [Full Text] [Related]
2. Editorial.
Baxter G
Clin Radiol; 2017 Jan; 72(1):1-2. PubMed ID: 27836105
[No Abstract] [Full Text] [Related]
3. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
Elshafeey N; Hassan I; Zinn PO; Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Review of Genomics and Noncoding RNA in Gliomas.
Hassan A; Mosley J; Singh S; Zinn PO
Top Magn Reson Imaging; 2017 Feb; 26(1):3-14. PubMed ID: 28079712
[TBL] [Abstract][Full Text] [Related]
5. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images.
Abrol S; Kotrotsou A; Salem A; Zinn PO; Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):43-53. PubMed ID: 28079714
[TBL] [Abstract][Full Text] [Related]
6. Repurposing the vaginal tampon for endometrial cancer detection.
Bakkum-Gamez JN
Biomark Med; 2015; 9(8):715-7. PubMed ID: 26230218
[No Abstract] [Full Text] [Related]
7. [Not Available].
Bode-Lesniewska B
Ther Umsch; 2017 Sep; 74(4):204-208. PubMed ID: 28950776
[No Abstract] [Full Text] [Related]
8. [Not Available].
Menter T; Tzankov A; Dirnhofer S
Ther Umsch; 2017 Sep; 74(4):197-203. PubMed ID: 28950777
[No Abstract] [Full Text] [Related]
9. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.
Sala E; Mema E; Himoto Y; Veeraraghavan H; Brenton JD; Snyder A; Weigelt B; Vargas HA
Clin Radiol; 2017 Jan; 72(1):3-10. PubMed ID: 27742105
[TBL] [Abstract][Full Text] [Related]
10. Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment.
Zapardiel I; Rajaram S; Piovano E; Petrillo M
Biomed Res Int; 2015; 2015():787080. PubMed ID: 26185763
[No Abstract] [Full Text] [Related]
11. Next-generation strategies for hereditary colorectal cancer risk assessment.
Yurgelun MB
J Clin Oncol; 2015 Feb; 33(5):388-93. PubMed ID: 25559814
[No Abstract] [Full Text] [Related]
12. Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia.
Langerbeins P; Groß-Ophoff-Müller C; Herling CD
Oncol Res Treat; 2016; 39(1-2):18-24. PubMed ID: 26891412
[TBL] [Abstract][Full Text] [Related]
13. New advance in breast cancer pathology and imaging.
Urbano N; Scimeca M; Bonfiglio R; Bonanno E; Schillaci O
Future Oncol; 2019 Aug; 15(23):2707-2722. PubMed ID: 31339050
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.
Hollis M; Nair K; Vyas A; Chaturvedi LS; Gambhir S; Vyas D
World J Gastroenterol; 2015 Jul; 21(27):8284-92. PubMed ID: 26217080
[TBL] [Abstract][Full Text] [Related]
15. Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia.
Tausch E; Mertens D; Stilgenbauer S
Oncol Res Treat; 2016; 39(1-2):34-40. PubMed ID: 26890126
[TBL] [Abstract][Full Text] [Related]
16. Genetic biomarkers of cancer risk.
Calzone KA
Semin Oncol Nurs; 2012 May; 28(2):122-8. PubMed ID: 22542320
[TBL] [Abstract][Full Text] [Related]
17. Routine testing for women with ovarian cancer.
Arie S
BMJ; 2014 Feb; 348():g1200. PubMed ID: 24574473
[No Abstract] [Full Text] [Related]
18. Neuro-Oncology and Radiogenomics: Time to Integrate?
Lasocki A; Rosenthal MA; Roberts-Thomson SJ; Neal A; Drummond KJ
AJNR Am J Neuroradiol; 2020 Nov; 41(11):1982-1988. PubMed ID: 32912874
[TBL] [Abstract][Full Text] [Related]
19. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
Boeri M; Sestini S; Fortunato O; Verri C; Suatoni P; Pastorino U; Sozzi G
Expert Rev Mol Diagn; 2015 Jun; 15(6):801-13. PubMed ID: 25924864
[TBL] [Abstract][Full Text] [Related]
20. Clinical Perspective of Prostate Cancer.
Patil N; Gaitonde K
Top Magn Reson Imaging; 2016 Jun; 25(3):103-8. PubMed ID: 27187167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
